MPM Oncology Impact Management GP LLC, 10% Owner at Harpoon Therapeutics, Inc. (HARP), sold 95,896 shares at $20.67 ($2.0M) on 2021-05-18, disclosed to the SEC on 2021-05-20.
Open-market sale of $2.0M HARP by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.67 | 18,402 | $380K | 19.4% |
| 2 | $20.67 | 18,402 | $380K | 19.4% |
| 3 | $20.39 | 17,833 | $364K | 18.5% |
| 4 | $20.39 | 17,833 | $364K | 18.5% |
| 5 | $20.34 | 11,713 | $238K | 12.1% |
| 6 | $20.34 | 11,713 |
| $238K |
| 12.1% |
| Total | $20.49 avg | 95,896 | $2.0M | 100% |
| Filing → |
| HARP | SELL | 2021-05-17 | $520K | — | Filing → |
| HARP | SELL | 2021-05-04 | $14.7M | — | Filing → |
| HARP | SELL | 2021-04-22 | $330K | — | Filing → |